Pantoprazole Domperidone Pellets Manufacturer & Supplier

Anti-Ulcerant (PPIs) • Pellets

Combination pellets balancing acid suppression with antiemetic action, optimised for capsule blends without segregation.

40 mg + 30 mg
  • GradeIP / BP / USP / EP
  • Pack Size25/50 kg
  • CertificationsWHO-GMP • ISO 9001

Product overview

Pantoprazole provides proton pump inhibition, while Domperidone is used as the prokinetic component. Rraynex focuses on density uniformity, particle-size consistency, moisture control, and formulation-specific dissolution to support reproducible manufacturing and downstream handling.

Key characteristics

  • Dual-API multiparticulate platform.
  • Controlled protection of the PPI component.
  • Uniform pellet density for reduced segregation.
  • Suitable for capsule, sachet, and multiparticulate applications.
  • Technical support for formulation development and scale-up.

Product specifications

Product
Pantoprazole Domperidone Pellets
Form
Pellets
Therapeutic category
Anti-Ulcerant (PPIs)
Strength
40 mg + 30 mg
Grade
IP / BP / USP / EP
Pack size
25/50 kg
Site certifications
WHO-GMP, ISO 9001, ISO 14001

Detailed specifications, COA and technical documentation are shared on request.

Supply and enquiries

Rraynex supplies Pantoprazole Domperidone Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.

Send product enquiry Browse all pellets Manufacturing capabilities

Other Pantoprazole products from Rraynex

Frequently asked questions

Enquire Now